search
Back to results

Efficacy of Aurosling in Frontalis Sling Suspension Surgery

Primary Purpose

Ptosis, Eyelid

Status
Completed
Phase
Phase 4
Locations
India
Study Type
Interventional
Intervention
Aurosling
Sponsored by
Aurolab
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ptosis, Eyelid focused on measuring Blepharoptosis, Ophthalmoplegia, Blepharospasm

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Congenital Ptosis
  • Severe Ptosis (MRD<0)
  • Poor levator function (<4mm by Berke's method)
  • Myogenic Ptosis (Myasthenia gravis)
  • Chronic progressive external ophthalmoplegia
  • Neurogenic Ptosis (Third cranial palsy)
  • Blepharospasm
  • Ptosis caused by trauma

Exclusion Criteria:

  • Acquired Ptosis
  • Horners syndrome
  • Blepharochalasis/Dermatochalasis
  • Mechanical Ptosis
  • Mild or Moderate Ptosis (MRD 1>1)
  • Good or fair levator function (>4 mm by Berke's method)
  • Previous Ptosis surgery
  • Ptosis associated syndromes/Other anomalies including
  • Marcus Gunn jaw winking syndrome
  • Blepharophimosis syndrome
  • Dry eye syndromes
  • Corneal anesthesia
  • Medical/Pediatric/Anesthesia condition contraindicating to surgery or anesthesia
  • Nystagmus where adequate measurements could not be done
  • Uncorrected vertical squint of any sort

Sites / Locations

  • Aravind Eye Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

1

Arm Description

Aurosling

Outcomes

Primary Outcome Measures

Ptosis Correction

Secondary Outcome Measures

Adverse Events

Full Information

First Posted
September 16, 2008
Last Updated
July 11, 2012
Sponsor
Aurolab
search

1. Study Identification

Unique Protocol Identification Number
NCT00753831
Brief Title
Efficacy of Aurosling in Frontalis Sling Suspension Surgery
Official Title
Randomized, Double Blind, Active Controlled Study of the Efficacy, Surgical Outcome and Complications of Silicone Rod Sling in Frontalis Sling Suspension Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
July 2012
Overall Recruitment Status
Completed
Study Start Date
January 2009 (undefined)
Primary Completion Date
July 2009 (Actual)
Study Completion Date
August 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Aurolab

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To Study the Efficacy of Aurosling as a suspension material in Frontalis suspension surgery in ptosis
Detailed Description
Silicon rod is an effective and safe material used in frontalis suspension in treating ptosis with poor levator function.The elasticity and ease of adjustment of silicon rod are ideal characteristics for suspension material used to treat severe ptosis in patients with poor bells phenomenon. In the present study , we attend to study the efficacy of aurosling silicon material as a suspension material for frontalis sling surgery

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ptosis, Eyelid
Keywords
Blepharoptosis, Ophthalmoplegia, Blepharospasm

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Aurosling
Intervention Type
Procedure
Intervention Name(s)
Aurosling
Intervention Description
Silicon rod to be used in frontalis suspension surgery
Primary Outcome Measure Information:
Title
Ptosis Correction
Time Frame
15th day, 90th day postoperatively
Secondary Outcome Measure Information:
Title
Adverse Events
Time Frame
15th day, 90th day postoperatively

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Congenital Ptosis Severe Ptosis (MRD<0) Poor levator function (<4mm by Berke's method) Myogenic Ptosis (Myasthenia gravis) Chronic progressive external ophthalmoplegia Neurogenic Ptosis (Third cranial palsy) Blepharospasm Ptosis caused by trauma Exclusion Criteria: Acquired Ptosis Horners syndrome Blepharochalasis/Dermatochalasis Mechanical Ptosis Mild or Moderate Ptosis (MRD 1>1) Good or fair levator function (>4 mm by Berke's method) Previous Ptosis surgery Ptosis associated syndromes/Other anomalies including Marcus Gunn jaw winking syndrome Blepharophimosis syndrome Dry eye syndromes Corneal anesthesia Medical/Pediatric/Anesthesia condition contraindicating to surgery or anesthesia Nystagmus where adequate measurements could not be done Uncorrected vertical squint of any sort
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Usha Kim, DO, Dip NB
Organizational Affiliation
Aravind Eye Hospital, Madurai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aravind Eye Hospital
City
Madurai
State/Province
Tamil Nadu
ZIP/Postal Code
625020
Country
India

12. IPD Sharing Statement

Learn more about this trial

Efficacy of Aurosling in Frontalis Sling Suspension Surgery

We'll reach out to this number within 24 hrs